Track and Trace Roundtable in American Pharmaceutical Review

Glenn Siegele, President of Omega Design Corporation, was one of three featured panelists in a serialization roundtable article published in the American Pharmaceutical Review.

Questions asked include:

  • Many regulations for track-and trace and serialization are still being finalized. What advice can you give to a pharma company that wants to be prepared?
  • What anti-counterfeiting and anti-diversion technologies show the most promise to thwart illegal activities and why?
  • What are some of the biggest barriers to implement track and trace technologies? Cost? Complexity? Lack of regulatory guidelines?
  • What segment of the industry is really driving advances in track and trace/serialization? Government? Industry? Vendors? Why? Who has the most to gain, or lose?
  • Do you foresee regulatory agencies around the globe coming to a joint consensus on track and trace regulations in the near future?

Read the answers here.